Anticoagulants in heart disease: current status and perspectives
Open Access
- 23 March 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 28 (7) , 880-913
- https://doi.org/10.1093/eurheartj/ehl492
Abstract
In contrast to FXa, FIXa is not inhibited by TFPI, and only slowly inhibited by antithrombin (AT). FIXa moves in the fluid phase from TF-bearing cells to nearbyThis publication has 2 references indexed in Scilit:
- A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluationJournal of Thrombosis and Haemostasis, 2004
- Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable anginaJournal of the American College of Cardiology, 2001